Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g, 10g
- Available purity: >97%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 21009-57-4
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>97% |
2
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
>97% |
2
In Stock
|
Shenzhen |
Inquiry |
| 1g |
>97% |
2
In Stock
|
Beijing |
Inquiry |
| 5g |
>97% |
2
In Stock
|
Hong Kong |
Inquiry |
| 10g |
>97% |
2
In Stock
|
Beijing |
Inquiry |
21009-57-4 / morpholine-3-thione
Standard CAS: 21009-57-4
Multi CAS: No
Basic Information
CAS
21009-57-4
Multi CAS
No
Molecular Formula
C4H7NOS
Molecular Weight
117.170000
Exact Mass
117.024835
SMILES
C1COCC(=S)N1
InChI
InChI=1S/C4H7NOS/c7-4-3-6-2-1-5-4/h1-3H2,(H,5,7)
InChIKey
LTAFRIZVOKDEMU-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
7
Fraction Csp3
0.75
H-bond acceptors
2
H-bond donors
1
Molar refractivity
31.42
TPSA
21.26
LogP / Solubility
WLOGP
-0.07
MLOGP
-0.07
XLogP3
-0.2
Consensus LogP
-0.11
Log S (ESOL)
-0.52
Class (ESOL)
Very soluble
Log S (Ali)
-0.47
Class (Ali)
Very soluble
Log S (SILICOS-IT)
-0.37
Class (SILICOS-IT)
Very soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.48
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5